Mark,

The study was specifically designed to determine the effects of Gangrenous dermatitis, and did not require the expense of a full 22 week study.  Once the birds were infected, they were no longer fit for market.  The test only went long enough to collect the required data.  The test required that the birds that didn''t die from the disease be sacrificed to collect accurate lesion scores. 

There are other tests on performance that do not involve bacterial challenge, and will allow the birds to go to full market weight.  These tests involve 100's of thousands of birds, and use a lot of product. 

As to the status of those tests, there are currently trials being done in several markets, with ducks, broilers, turkeys, pigs, and dairy cattle.  Those tests are ongoing, and are at various stages of completion. 

Trials sometimes produce results that are skewed, or unanticipated, and require a second, or even a third round of testing.  Sometimes, the results are skewed so much in favor of Agrastim, that the producer says, "Whoa, lets do that again, because that seems too good to be true." 

There are also times when things go wrong, because some well meaning farm technician screws up the test.....or something like the  pre-mix needs fine tuning because it works great in small hand mixed batches, but doesn't produce the same results in big batches.  Who would have thought?  The product obviously works, but there is a glitch when feeding 200,000 turkeys or 500 pigs.  SO, you go back and identify the reason, you fix it, and you do another trial.  Sometimes when the trial works, you do it again to confirm it wasn't an anomaly. 

I am as impatient as the next guy, but I am greatly encouraged by the results of ongoing tests, and the fact that producers are also sufficiently impressed so as to continue testing, and responding positively to the results.   I am also pleased that the favorable results of the Gangrenous dermatitis test came out in time to be premiered at the International Poultry Expo, and the results to be receiving a lot of attention.

As to charts and graphs:   I believe the "scientific types" at BIOAGRA are working on putting the data in a form more understandable for the layman. 

As to how the processor responded to the results of the study: The results speak for themselves.  Beyond that......

I don't know yet. 

Best regards,

z